Scarica l'app Stockscreener
113.17
2.38%
2.63
Pre-mercato:
114.51
1.34
+1.18%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché RVTY Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Revvity Inc Borsa (RVTY) Ultime notizie
Revvity Inc. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
Revvity Announces Development of High-Throughput T-SPOT.TB Automated Platform for Clinical Labs - FinancialContent
Revvity, Inc. (RVTY) stock price, news, quote and history - Yahoo Finance UK
Revvity, Inc. (RVTY) Stock Price, News, Quote & History - Yahoo! Finance Canada
Revvity, Inc. (RVTY) Q3 2024 Earnings ReportResults, Call & Slides - TipRanks
Insider Sell Alert: Anita Gonzales Sells Shares of Revvity Inc (RVTY) - GuruFocus
How Revvity’s (RVTY) Startup Software Push and ESG Disclosures Reframe Its Competitive Positioning - simplywall.st
Revvity to Launch Signals for Startups for Emerging Biotech Companies - The Globe and Mail
Revvity Inc. Stock Slides 3.4%, Underperforms Peers - webull.com
Revvity stock holds steady as Q1 2026 growth and margin expansion underpin valuation - Ad-hoc-news.de
Precision Trading with Revvity Inc. (RVTY) Risk Zones - Stock Traders Daily
Revvity Inc (RVTY) Stock Down 3.4% -- Now Undervalued? GF Score: 72/100 - GuruFocus
Revvity Inc. stock underperforms Monday when compared to competitors - MarketWatch
Revvity Launches “Signals for Startups” to Help Emerging Biotechs Build Scalable Digital Foundations from Day One - 01net
RVTY (RVTY) investor files notice to sell 85 common shares - Stock Titan
Revvity (NYSE: RVTY) removes 1.875% notes due 2026 from NYSE listing - Stock Titan
Revvity launches “Signals for Startups” to give emerging biotechs an enterprise-grade digital edge - Indian Chemical News
Revvity Releases 2026 Impact Report Advancing Transparency with Initial Scope 3 Emissions Disclosure - Lelezard
Revvity stock trades steadily as recent earnings highlight margin focus - Ad-hoc-news.de
PKI5144059 Bond Coupon Profile — Rate & Payments - TradingView
Revvity (NYSE: RVTY) VP Gonzales sells 85 shares under 10b5-1 plan - Stock Titan
PKI5144059 Bond Profile — Key Metrics - TradingView
XS1405780617 Bond Coupon Profile — Rate & Payments - TradingView
XS1405780617 Bond Risk Profile - TradingView
PKI5255604 Bond Risk Profile - TradingView
XS1405780617 Bond Profile — Key Metrics - TradingView
Revvity stock trades steady as genomics and diagnostics revenue underpins valuation - Ad-hoc-news.de
Revvity, Inc. (PKN) Q1 2024 Earnings ReportResults, Call & Slides - TipRanks
Revvity, Inc. (PKN) Q3 2024 Earnings ReportResults, Call & Slides - TipRanks
Revvity Inc. stock underperforms Friday when compared to competitors - MarketWatch
PKI5255604 Bond Profile — Key Metrics - TradingView
PKI5255604 Bond Coupon Profile — Rate & Payments - TradingView
Revvity stock trades steadily as recent earnings highlight growth and margin pressure - Ad-hoc-news.de
Revvity Inc. stock outperforms competitors on strong trading day - MSN
Revvity (RVTY) Q4 2025 earnings summary - Quartr
TD Cowen Adjusts Price Target on Revvity to $130 From $120, Maintains Buy Rating - marketscreener.com
REVVITY INC : TD COWEN RAISES TARGET PRICE TO $130 FROM $120 - Moomoo
TD Cowen Maintains Revvity(RVTY.US) With Buy Rating, Raises Target Price to $130 - Moomoo
Revvity (RVTY) Investor Day 2024 Summary - Quartr
Revvity (RVTY) TD Cowen 46th Annual Health Care Conference Summary - Quartr
Revvity (RVTY) Citi Annual Global Healthcare Conference 2025 Summary - Quartr
PKI4882935 Bond Risk Profile - TradingView
A184AM Bond Risk Profile - TradingView
A184AM Bond Coupon Profile — Rate & Payments - TradingView
S&P Global upgrades Revvity outlook on leverage improvement By Investing.com - Investing.com Nigeria
A184AM Bond Profile — Key Metrics - TradingView
PKI5255603 Bond Profile — Key Metrics - TradingView
S&P Global upgrades Revvity outlook on leverage improvement - Investing.com
Revvity: Overvalued On Sentiment (NYSE:RVTY) - Seeking Alpha
The path to AI federated learning for drug discovery - Scientific Computing World
Baird Adjusts Price Target on Revvity to $128 From $117, Maintains Outperform Rating - marketscreener.com
Revvity, Inc. Stock 12‑Month Price Target Raised to $116.07, Implies 3% Upside - TradingView
Revvity, Inc. (RVTY) Stock Analysis: Navigating Growth with a 7% Revenue Rise and Analyst Insights - DirectorsTalk Interviews
ETFs Investing in Revvity, Inc. Stocks - TradingView
RVTY Stock Price and Chart — NYSE:RVTY - TradingView
Revvity expands Signals AI with Anthropic Claude integration - MSN
Should Revvity’s (RVTY) Claude Integration Reframe How Investors View Its Data and AI Strategy? - Yahoo Finance
Revvity Inc (RVTY) Stock Up 3.3% and Still Undervalued -- GF Sco - GuruFocus
Revvity (RVTY) Joins Anthropic Directory To Bring Claude Into Signals Research Workflows - Yahoo Finance
Revvity Inc. focuses on life sciences tools as investors watch fundamentals - Ad-hoc-news.de
Revvity Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Revvity to announce Q2 2026 results on August 4 - scanx.trade
Press Release: Revvity to Hold Earnings Call on Tuesday, August 4, 2026 - Moomoo
Revvity to Hold Earnings Call on Tuesday, August 4, 2026 - Business Wire
Revvity Inc. outlines its life sciences focus as a diversified tools provider - Ad-hoc-news.de
Revvity Inc. outlines its life sciences focus as investors track its Nasdaq listing - ad-hoc-news.de
8.61%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):